We undertook a non-concurrent prospective study of 191 Puerto Rican patients from August
1993 to April 1994. All patients had open angle glaucoma (OAG)(age ranged from 50 to 80 …

F., major classes of drugs are currently used to treat glaucoma: beta-adrenergic blockers,
carbonic anhydrase inhibitors, sympathomimetics, and parasympathomimet-ics. Both local …

The safety profile of the different glaucoma medications is an important issue when initiating
therapy in glaucomatous patients. The decision on which medication to prescribe depends …

Glaucoma is a chronic, progressive disease in which retinal ganglion cells disappear and
subsequent, gradual reductions in the visual field ensues. Glaucoma eye drops have …

Drug treatment of glaucoma is reviewed. Ocular physiology, open-angle glaucoma and
narrow-angle glaucoma are discussed. The primary treatment of narrow-angle glaucoma is …

Glaucoma and ocular hypertension are highly prevalent conditions in individuals over the
age of 40 and are commonly seen together in patients with cardiovascular disease. Many of …

We conducted a case-control study to measure the risk of pulmonary side effects following
the use of topical glaucoma medications, particularly the [beta] blockers, and to identify …

The review is based on a survey of studies on adverse reactions related to topical
administration of beta-blockers for glaucoma. Locally applied beta-blocking agents are …

Medications used to treat glaucoma can have clinically important systemic effects in some
patients; these effects may not be recognized in elderly patients who have chronic medical …

A brief review of the common systemic side effects of the various medications used to treat
glaucoma on an outpatient basis has been presented. This review is not complete, and the …